Here are the latest quarterly results of Procter & Gamble Health. For more details, see the Procter & Gamble Health financial fact sheet and Procter & Gamble Health share price and chart. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-19 |
3
Jun-19 |
3
Sep-19 |
3
Dec-19 |
3
Mar-20 |
3
Jun-20 |
3
Sep-20 |
3
Dec-20 |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 2,310 | 2,336 | 2,252 | 2,368 | 2,281 | 6,345 | 10,095 | 10,184 | |
Other income | Rs m | 177 | 175 | 67 | 61 | 103 | 96 | 96 | 94 | |
Turnover | Rs m | 2,487 | 2,511 | 2,319 | 2,428 | 2,384 | 6,441 | 10,190 | 10,278 | |
Expenses | Rs m | 1,809 | 1,791 | 1,753 | 1,877 | 1,694 | 5,242 | 6,712 | 6,760 | |
Gross profit | Rs m | 501 | 545 | 499 | 490 | 587 | 1,103 | 3,383 | 3,424 | |
Depreciation | Rs m | 43 | 45 | 40 | 43 | 42 | 132 | 118 | 120 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | 10 | 4 | 21 | |
Profit before tax | Rs m | 635 | 675 | 526 | 508 | 648 | 1,056 | 3,357 | 3,377 | |
Tax | Rs m | 228 | 234 | 168 | 126 | 183 | 364 | 818 | 871 | |
Profit after tax | Rs m | 407 | 441 | 358 | 382 | 465 | 692 | 2,539 | 2,506 | |
Gross profit margin | % | 21.7 | 23.3 | 22.2 | 20.7 | 25.8 | 17.4 | 33.5 | 33.6 | |
Effective tax rate | % | 35.9 | 34.7 | 32.0 | 24.8 | 28.3 | 34.5 | 24.4 | 25.8 | |
Net profit margin | % | 17.6 | 18.9 | 15.9 | 16.1 | 20.4 | 10.9 | 25.1 | 24.6 | |
Diluted EPS | Rs | 24.5 | 26.6 | 21.5 | 23.0 | 28.0 | 41.7 | 152.9 | 151.0 | |
Diluted EPS (TTM) | Rs | 77.2 | 84.0 | 80.7 | 95.6 | 99.1 | 114.2 | 245.6 | 373.6 | |
![]() |
Read: Procter & Gamble Health 1QFY21 Result Performance Review
More Pharmaceuticals Company Quarterly Results: LUPIN INDRAPRASTHA MEDICAL DISHMAN PHARMA PANACEA BIOTECH INDOCO REMEDIES
Compare PROCTER & GAMBLE HEALTH With: LUPIN INDRAPRASTHA MEDICAL DISHMAN PHARMA PANACEA BIOTECH INDOCO REMEDIES
Compare PROCTER & GAMBLE HEALTH With: ACTAVIS (US) MYLAN (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.
For the quarter ended June 2020, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 692 m (up 57.0% YoY). Sales on the other hand came in at Rs 6 bn (up 171.6% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.
For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.
Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
This could take India to the position of 3rd largest economy.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More